US20070292364A1 - Method for measurably improving oral health - Google Patents
Method for measurably improving oral health Download PDFInfo
- Publication number
- US20070292364A1 US20070292364A1 US11/749,099 US74909907A US2007292364A1 US 20070292364 A1 US20070292364 A1 US 20070292364A1 US 74909907 A US74909907 A US 74909907A US 2007292364 A1 US2007292364 A1 US 2007292364A1
- Authority
- US
- United States
- Prior art keywords
- composition
- centipoise
- viscosity
- zinc
- oral health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 230000036541 health Effects 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 143
- 239000004480 active ingredient Substances 0.000 claims abstract description 41
- 208000006558 Dental Calculus Diseases 0.000 claims description 33
- 239000002562 thickening agent Substances 0.000 claims description 23
- -1 alkyl dimethyl amine oxide Chemical compound 0.000 claims description 20
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 18
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 18
- 210000000214 mouth Anatomy 0.000 claims description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 239000011670 zinc gluconate Substances 0.000 claims description 10
- 235000011478 zinc gluconate Nutrition 0.000 claims description 10
- 229960000306 zinc gluconate Drugs 0.000 claims description 10
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 9
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 8
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
- 150000003751 zinc Chemical class 0.000 claims description 7
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 6
- 239000001506 calcium phosphate Substances 0.000 claims description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 4
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 4
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 claims description 4
- 240000008025 Alternanthera ficoidea Species 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 4
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 4
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 239000005844 Thymol Substances 0.000 claims description 4
- 229960005233 cineole Drugs 0.000 claims description 4
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 4
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 4
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 4
- 108700003601 dimethylglycine Proteins 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 4
- 229940041616 menthol Drugs 0.000 claims description 4
- 229960001047 methyl salicylate Drugs 0.000 claims description 4
- 235000019477 peppermint oil Nutrition 0.000 claims description 4
- 239000010670 sage oil Substances 0.000 claims description 4
- 235000012420 sanguinaria Nutrition 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 229960001790 sodium citrate Drugs 0.000 claims description 4
- 235000011083 sodium citrates Nutrition 0.000 claims description 4
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 4
- 229960002799 stannous fluoride Drugs 0.000 claims description 4
- 229960000790 thymol Drugs 0.000 claims description 4
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 3
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 3
- 239000004246 zinc acetate Substances 0.000 claims description 3
- 229960000314 zinc acetate Drugs 0.000 claims description 3
- 235000013904 zinc acetate Nutrition 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- 229960001939 zinc chloride Drugs 0.000 claims description 3
- 239000011746 zinc citrate Substances 0.000 claims description 3
- 235000006076 zinc citrate Nutrition 0.000 claims description 3
- 229940068475 zinc citrate Drugs 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 229960002900 methylcellulose Drugs 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 208000007565 gingivitis Diseases 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 10
- 239000003086 colorant Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 230000001680 brushing effect Effects 0.000 description 6
- 210000004195 gingiva Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 201000001245 periodontitis Diseases 0.000 description 6
- 239000000902 placebo Substances 0.000 description 6
- 229940068196 placebo Drugs 0.000 description 6
- 239000002324 mouth wash Substances 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000024693 gingival disease Diseases 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000005802 health problem Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 208000008312 Tooth Loss Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000010630 cinnamon oil Substances 0.000 description 2
- 239000010634 clove oil Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 210000004513 dentition Anatomy 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000011759 gum bleeding Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000036346 tooth eruption Effects 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000036367 tooth discoloration Effects 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention generally relates to methods for measurably improving oral health. More particularly, the invention relates to techniques for measurably reducing an amount of plaque, tartar, gingivitis, periodontitis, and/or bleeding of the gums
- Plaque can be defined as an organized, coherent, gel-like or mucoid material that includes microorganisms in an organic matrix derived from saliva and extracellular bacterial products such as glucans, fructans, enzymes, toxins, and acids. Plaque may also contain other cells, such as desquamated epithelial cells, and inorganic components, such as calcium and phosphate.
- dental plaque is a bacterial accumulation. Generally transparent and sticky, plaque accumulates around the teeth at the cervical margin, and then grows apically.
- plaque forms on a surface, the plaque resists removal, and usually can be removed only by mechanical means, such as, for example, by brushing and flossing the affected areas. If not removed, however, the presence of plaque can give rise to tartar formation, tooth decay, gingivitis, periodontitis, and other health problems.
- Tartar is a hard, calcified plaque material that exhibits a yellowish or brownish color. Tartar forms as a result of minerals (e.g., those present in saliva and gum pockets) reacting with plaque material to form a rough calculus. Calculus generally arises from the nucleation of calcium phosphate, often in areas where the large salivary gland ducts secrete their saliva. As such, calculus can form on surfaces not covered by the oral mucosa (supragingival) or on surface located apical to the soft tissue margin of the gingiva (subgingival).
- tartar buildup can be problematic in several regards.
- the rough, porous surface of tartar serves as a breeding ground for additional bacteria, which can calcify and form additional tartar.
- the bacteria growth from both plaque and tartar can, in turn, lead to tooth decay, gum disease, gingivitis, periodontitis, tooth loss, as well as systemic health problems.
- Gingivitis is the beginning stage of periodontitis and is often caused by long-term effects of plaque and tartar buildup. Gingivitis is characterized by red, swollen gums. A periodontal probe will often measure about 3 to about 5 mm in depth into the space between the teeth and gums at the early stages of gingivitis. At this stage, gingivitis can often be reversed with proper treatment.
- gingivitis will likely progress to advanced periodontitis.
- plaque and tartar are typically present supragingival and subgingival and an infection has destroyed bone around a tooth.
- a family of chronic inflammatory infections are affecting the supporting tissues of the dentition. Teeth often become loose, and the pocket depth may range between about 5 mm and about 8 mm at this stage.
- Tartar can be particularly problematic because it is difficult to remove and because of its yellowish or brownish color.
- tartar tends to absorb colors from other sources (e.g., coffee, tea, tobacco, smoke, red wine and the like), and thus the presence of tartar exacerbates cosmetic tooth coloration typically associated with such other sources.
- Typical self-administered techniques for promoting oral health include brushing, flossing, and rinsing with a mouth rinse that typically includes an antimicrobial agent. Although such techniques may work relatively well at mitigating plaque buildup, such techniques are not thought to be effective at removing existing tartar from a surface. Furthermore, although flossing is thought to reduce plaque buildup, relatively few people in the general population floss as often as they should (at least once a day). In a recent study, only 27% of consumers said they flossed once a day.
- the usual methods of preventing tartar buildup include brushing with a tartar control toothpaste. Although such toothpastes, if used regularly, may prevent additional buildup of tartar, the toothpastes are not thought to be effective at removing existing tartar from tooth and device surfaces.
- Typical methods of removing existing tartar typically include scaling or root planing, both of which are performed by dentists or hygienists with the aid of specialized tools. Although these techniques work well, they are relatively expensive and time consuming.
- the present invention provides a method for measurably improving oral health. More particularly, the invention provides techniques for using a composition, system, and kit.
- the composition includes one or more active ingredients to measurably reduce an amount of plaque, tartar, gingivitis, including gum bleeding, and/or other periodontal disease
- a system includes the composition and a container
- a kit includes a plurality of systems.
- the present invention provides a relatively inexpensive, safe technique for the measurable improvement of oral care indices, such as Loe and Silness Gingival Index (1963) (GI), the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI), Volpe-Manhold Index for Calculus (1965) (V-MI).
- GI Loe and Silness Gingival Index
- PI Quiqley and Hein Plaque Index
- V-MI Volpe-Manhold Index for Calculus (1965)
- the method is relatively easy to use, does not require a visit to a dentist office, and does not damage the surface of tooth enamel.
- a method for measurably improving oral health includes use of a system that includes a composition, having one or more active ingredients to measurably improve oral health, and a container for enclosing and applying the composition.
- a system in accordance with one embodiment of the invention, includes a viscous composition including at least one active ingredient and a container configured to dispense the viscous composition.
- the viscous composition is designed to maintain the active ingredient(s) in contact with a surface for an extended period of time.
- Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
- the viscosity of the compositions may range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp.
- Suitable active ingredients include cetylpyridinium chloride (CPC), zinc salts, other antimicrobial agents, and other ingredients known to improve (typically reduce) measurable oral health care indices.
- the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses.
- the container is configured to facilitate application of the composition to specific areas within an oral cavity.
- the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- a system in accordance with another embodiment of the invention, includes a composition, having a plurality of active ingredients to measurably improve oral health, and a container to hold the composition.
- the composition includes a carrier having a thickening agent, wherein the composition is configured to maintain the plurality of active ingredients in contact with a surface for an extended period of time.
- Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to reduce tartar or plaque or gingivitis.
- the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses.
- the container is configured to facilitate application of the composition to specific areas within an oral cavity.
- the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- a system in accordance with a further embodiment of the invention, includes a composition, having one or more active ingredients to measurably improve oral health and a carrier including a thickening agent, and a container to hold the composition.
- exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, glycerin, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to improve oral health.
- a system includes a container that encapsulates a single dose of the composition.
- the container encloses multiple doses.
- compositions, system, and kit are designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- a method includes dispensing a composition from a sealed container by rupturing the sealed container and applying a single dose of the composition directly to the surface.
- the composition is applied after brushing, flossing, and/or rinsing, and is applied before extended rest or bedtime to allow the active ingredients to stay in contact with a surface for an extended period of time
- FIG. 1 illustrates a perspective view of a dispensing device in accordance with exemplary embodiments of the invention
- FIGS. 2A-2D illustrate, respectively, left view, front view, right view and a top view of an exemplary container in accordance with an exemplary embodiment of the invention.
- the present invention provides a method to measurably improve oral health. More particularly, the invention provides a method for using a composition, system, and kit to measurably improve one or more oral health care indices such as GI, PI, and V-MI.
- the method of the invention can be used to improve oral health of various animals, is particularly well suited for the treatment of humans.
- the term “surface” includes any surface on which plaque, tartar, or gum disease may form.
- Exemplary surfaces include teeth (both supragingival and subgingival), gums, and dental appliances such as bridges, crowns, fillings, braces, and the like.
- the term “measurably improve” means a measurable difference between an amount measured without use of the system of the present invention and with or after use of the system. The measurements may be compared for the same surface (before and after) or between test and control groups.
- a method for measurably improving oral health includes a use of a viscous composition, including an active ingredient.
- the composition is designed to maintain the active ingredient in contact with a surface for an extended period of time to allow the active ingredient(s) to stay in contact with possibly affected areas on the surface.
- Exemplary active ingredients suitable for use with systems of the invention include one or more of the following: cetylpyridinium chloride (CPC), dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, sodium fluoride, stannous fluoride, sodium monofluorophosphate (MFP), zinc salts such as zinc chloride, zinc acetate, zinc citrate, zinc oxide and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
- CPC cetylpyridinium chloride
- dicalcium phosphate dehydrate hydrogen peroxide
- sanguinaria extract sodium bicarbonate
- sodium lauryl sulfate sodium fluoride
- any agent which alone or in combination is able to prevent or alleviate the severity of problems associated with dentition may be utilized.
- agents useful in reducing tooth hypersensitivity such as potassium nitrate, strontium chloride and/or the like
- plaque and calculus reducing agents such as, for example, chlorhexidine, quaternary ammonium compounds (e.g. benzethonium chloride, domphen bromide, etc.), triclosan, herbal compounds (e.g. sanguinarine), stannous salts, complex phosphates (e.g., pyrophosphates), SLS (e.g. sodium lauryl sulfate), hydrogen peroxide, and/or the like.
- an amount of the active ingredient for use within compositions suitable for uses with the invention varies in accordance with the dosage size and particular ingredient(s).
- each active or actives selected will be used in a suitably effective amount, generally on the order of less than about 10 wt %, and more preferably 5 wt % or less.
- An amount of active may also be desirably selected to be within government guidelines, such as guidelines by the Food and Drug Administration in the USA.
- the active ingredient is present in an amount of about 0.001 wt % to about 1.5 wt %, within an amount of about 0.025 wt % to about 1.0 wt %, or even within an amount about 0.05 wt % to about 0.7 wt %. All percentages set forth herein are in weight percent of the total composition, unless otherwise indicated.
- the active ingredient includes CPC.
- the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%.
- the active ingredient includes zinc gluconate.
- the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
- the composition includes a thickener to obtain the desired viscosity.
- suitable thickening agents include substances which increase the viscosity of the composition, cause the composition to gel or coagulate, or the like, such as food-grade or pharmaceutical grade thickeners, including, for example, hydroxyethylcellulose.
- hydroxyethylcellulose For example, hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, methyethylecellulose, acceptable non-ionic thickeners, and/or the like.
- the thickener may be present in an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- the composition may also include a humectant such as a glycerin, which may be present in an amount of about 0.01% to about 15%, preferably about 0.1% to about 10%, and more preferably about 1 to about 7%.
- a humectant such as a glycerin
- the humectant may facilitate maintaining the composition in a liquid form and may help maintain a desired viscosity of the composition.
- glycerin may facilitate maintaining one or more of the active ingredients in an ionic form and may facilitate the transport of the active ingredients through the composition.
- the composition may also include a suitable diluent.
- exemplary diluents for use with the present composition include water, alcohols, and oils.
- the composition includes purified water in an amount of about 80% to about 99%, preferably about 85% to about 95%, and more preferably about 88% to about 92%.
- the composition may also include sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier.
- sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier.
- sorbitol or other sugar alcohol is present in an amount of about 0.001% to about 0.5%, preferably about 0.01% to about 0.1%, and more preferably about 0.025% to about 0.075%.
- the composition may also include a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
- a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
- Colorants may also be added to the composition as desired.
- the composition includes colorants, such that when the composition is applied to or proximate the gingiva, the composition has a color indicative of healthy gingiva—i.e., the composition is pink in color. Providing a composition having a color indicative of healthy gingiva provides added incentive to users to continue using the composition, which in turn promotes measurable improvement in oral health indices.
- Colorants may be present in any desired amount.
- the colorants may include Red #33 and Red #40, available from Pylam in an amount of about 0.000001% to about 0.00018%, and more preferably about 0.00050% to about 0.00099.
- the composition also optionally includes flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like.
- flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like.
- a composition includes cinnamon oil present in an about of about 0.001% to about 2%, preferably about 0.01% to about 1%, and more preferably about 0.1% to about 0.5%; and clove oil in an amount of about 0.001% to about 2%, preferably about 0.002% to about 1%, and more preferably about 0.003% to about 0.0075%.
- the composition is configured to maintain the composition in contact with a surface for an extended period of time, which has several advantages over traditional compositions used to promote oral health.
- the composition is both viscous and exhibits high micro adhesiveness.
- the composition is both viscous and “sticks” to a surface to which it is applied.
- the configuration of the composition permits relatively small amounts of the composition and consequently the active agent(s) to be used to effectively prevent or remove plaque and/or tartar buildup on a surface. This is advantageous, not only from an economic viewpoint, but it also reduces an amount of the composition that may be ingested.
- the viscosity of the composition is suitably selected to facilitate easy delivery of the composition from its container, while also maintaining the composition in contact at particular areas within an oral cavity, such as the crevices within teeth and at the tooth gingival margin.
- the viscosity is low enough to allow application of the composition to desired locations within the oral cavity.
- compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
- the viscosity of compositions range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp.
- the viscosity values as set forth herein are measured using a Brookfield, Model DV-II+ Pro viscometer, spindle # 6, 10 RPM for 90 seconds at 25 C.
- a composition in accordance with another embodiment of the invention, includes one or more active ingredients in a carrier, which includes a thickening agent.
- the active ingredient and thickening agent may include any one or more of the active ingredients and thickening agents noted above in the respective weight percents noted above.
- the composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
- a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients and hydroxyethylcellulose as the thickener.
- the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%
- the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%
- the hydroxyethylcellulose is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- a composition in accordance with another embodiment of the invention, includes multiple active ingredients.
- the plurality of active ingredients may include any combination of the active ingredients noted above in the weight percents noted above.
- the composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
- the composition has a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
- the viscosity of compositions ranges from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp.
- the composition includes a thickening agent, which is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients.
- the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25%; and the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
- a composition includes one or more active ingredients and a colorant indicative of healthy gingiva.
- the color of the composition is more than merely decorative. It serves the function of encouraging those that use the product to continue to use the product because there is an immediate appearance, upon application of the composition, that the composition is promoting healthy gingiva.
- FIG. 1 and FIGS. 2A-2D illustrate an enclosed, single-dose dispensing system 100 suitable for applying a composition 102 (e.g. a composition described herein) to a surface.
- System 100 includes a resilient containment portion 104 and an applicator portion 106 .
- Applicator portion 106 further includes a severed or scarred area 108 and a sealed end 110 .
- Composition 102 is dispensed from system 100 by severing or rupturing a portion of device 100 (e.g., at or near scarred area 108 ) to expose composition 102 contained within system 100 .
- Composition 102 is then expelled through applicator 106 to a desired area—e.g., a tooth gum margin of a user—by squeezing resilient portion 104 to cause the composition to flow from resilient portion 104 through applicator 106 .
- system 100 may be configured to apply a composition to a specific area within an oral cavity.
- applicator 106 may have a desirably small cross-section across applicator 106 .
- a cross-sectional dimension, taken along line A-A is about 0.001′′ to about 0.2′′, preferably about 0.05′′ to about 0.01′′, and more preferably about 0.06′′ to about 0.09′′.
- Resilient portion 104 is designed to fit comfortably between two fingers (e.g., a thumb and an index finger) of a user, such that the composition is expelled by pressing the two fingers, on opposite sides of portion 104 , together.
- portion 104 has a cross-sectional dimension, taken along line B-B, of about 0.1′′ to about 2′′, preferably about 0.25′′ to about 1′′, and more preferably about 0.4′′ to about 0.6′′.
- a single-dose size may vary in accordance with several factors, such as the particular active ingredient, the dilution of the composition, and the like.
- Exemplary dose sizes for purpose of illustration range from about 0.5 mg to about 8 mg, preferably about 1 mg to about 7 mg, and more preferably about 2 mg to about 5 mg.
- a method of measurably improving oral health includes applying a composition including one or more of the active ingredients described herein to a surface and maintaining the composition in contact with the surface for an extended period of time.
- composition may be applied using a variety of methods such as with a swab, with a syringe, or using any other means capable of dispensing the composition and applying a thin film of gel on the teeth and gums.
- the composition is selectively applied using system 100 . More particularly, composition 102 is applied though chute 106 to, e.g., a tooth/gingiva interface, such that the composition contacts both supragingival and subgingival areas where plaque and tartar is likely to form.
- the method of this embodiment allows for direct, selective application of the composition to desired areas of a surface. Thus, less composition may be required to perform the task of measurably improving oral health, because the composition is not ubiquitously applied to an oral cavity.
- a measurable difference of a gingivitis index (e.g., the Loe and Silness Gingival Index (1963)) is obtained by using the system of the present invention. More particularly, a measurable difference in the GI is obtained by applying a composition, e.g., from within the container, to an area (e.g., proximate an inflamed gum tissue, such as at the gum/tooth margin near the inflamed area).
- a single dose of the composition is applied after brushing teeth, flossing between teeth, and/or rinsing an oral cavity, and is applied such that the composition remains in contact with the affected area for an extended period of time.
- the composition can be applied at before an extended period of rest or bedtime to mitigate disruption of the composition/surface interface and to facilitate maintaining the composition in contact with the surface for an extended period.
- a measurable difference of a plaque index e.g., the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI) is obtained by using the method of the present invention.
- the method is used as described above in connection with obtaining a measurable difference in the GI.
- a measurable difference in a tartar index e.g., the Volpe-Manhold Index (V-MI)—is obtained by using the method of the present invention as described herein.
- a “measurable difference” means a reduction in one or more of the selected indices of on the order of about 20% or more.
- a measurable improvement in a stain index e.g., the Lobene Stain Index (SI)—is obtained using the system of the present invention.
- compositions for use in accordance with the present invention may include the ingredients listed below as well as additional and/or alternative inert materials, preservatives, and other constituents typically found in compositions for promoting oral health.
- inert materials and/or preservatives are listed, these ingredients are merely exemplary, and it is understood that other similar ingredients may be substituted for the materials listed in the examples below.
- a pale light pink viscous gel, having a viscosity of about 40,000 cp, with cinnamon-clove characteristic odor and taste is formed by admixing the following ingredients in the amounts shown.
- Example 1 A clinical study comparing the composition of Example 1 to a placebo and a commercial mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of the 6 week test period, there was an observable/measurable difference in the quality and thickness of calculus in the group using the composition of Example 1, compared to the placebo and the mouth rinse. A significant disruption of calculus bridges or masses of calculus was observed in subjects using the composition of Example 1.
- Example 1 A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the GI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse. The difference was statistically significant (p value ⁇ 0.05, based on ANCOVA results, adjusting for baseline value and multiple comparisons) in both absolute and percent improvement of GI between the groups.
- Example 1 A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the PI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides a method to measurably improve oral health. The method includes use of a composition, including one or more active ingredients to measurably improve oral health, a system including the composition and a container encapsulating the composition, and a kit including a plurality of systems. Each system is configured to apply the composition directly to a surface.
Description
- This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/800,632, entitled SYSTEM FOR MEASURABLY IMPROVING ORAL HEALTH AND METHOD OF USING SAME, filed May 15, 2006.
- The present invention generally relates to methods for measurably improving oral health. More particularly, the invention relates to techniques for measurably reducing an amount of plaque, tartar, gingivitis, periodontitis, and/or bleeding of the gums
- Unfortunately, poor oral health affects millions of people every year. Poor oral health may result in symptoms ranging bad breath, tooth decay, and tooth discoloration, to more serious health problems, such as gum disease, tooth loss, heart disease, stroke, poorly controlled diabetes and preterm labor.
- The presence of dental plaque, or simply plaque, in an oral cavity can lead to such oral and general health problems. Plaque can be defined as an organized, coherent, gel-like or mucoid material that includes microorganisms in an organic matrix derived from saliva and extracellular bacterial products such as glucans, fructans, enzymes, toxins, and acids. Plaque may also contain other cells, such as desquamated epithelial cells, and inorganic components, such as calcium and phosphate. In general, dental plaque is a bacterial accumulation. Generally transparent and sticky, plaque accumulates around the teeth at the cervical margin, and then grows apically.
- Once plaque forms on a surface, the plaque resists removal, and usually can be removed only by mechanical means, such as, for example, by brushing and flossing the affected areas. If not removed, however, the presence of plaque can give rise to tartar formation, tooth decay, gingivitis, periodontitis, and other health problems.
- Tartar is a hard, calcified plaque material that exhibits a yellowish or brownish color. Tartar forms as a result of minerals (e.g., those present in saliva and gum pockets) reacting with plaque material to form a rough calculus. Calculus generally arises from the nucleation of calcium phosphate, often in areas where the large salivary gland ducts secrete their saliva. As such, calculus can form on surfaces not covered by the oral mucosa (supragingival) or on surface located apical to the soft tissue margin of the gingiva (subgingival).
- Tartar adheres to hard surfaces such as enamel, roots, and dental devices, such as dentures, bridges, crowns, and the like, and is generally more difficult to remove than plaque. Brushing and flossing are normally not sufficient to remove tartar from a surface.
- If left untreated, tartar buildup can be problematic in several regards. For example, the rough, porous surface of tartar serves as a breeding ground for additional bacteria, which can calcify and form additional tartar. The bacteria growth from both plaque and tartar can, in turn, lead to tooth decay, gum disease, gingivitis, periodontitis, tooth loss, as well as systemic health problems.
- Gingivitis is the beginning stage of periodontitis and is often caused by long-term effects of plaque and tartar buildup. Gingivitis is characterized by red, swollen gums. A periodontal probe will often measure about 3 to about 5 mm in depth into the space between the teeth and gums at the early stages of gingivitis. At this stage, gingivitis can often be reversed with proper treatment.
- Left untreated, gingivitis will likely progress to advanced periodontitis. At this stage of gum disease, plaque and tartar are typically present supragingival and subgingival and an infection has destroyed bone around a tooth. In general, at this stage, a family of chronic inflammatory infections are affecting the supporting tissues of the dentition. Teeth often become loose, and the pocket depth may range between about 5 mm and about 8 mm at this stage.
- As noted above, in addition to the health concerns, plaque and tartar may give rise to cosmetic problems. Tartar can be particularly problematic because it is difficult to remove and because of its yellowish or brownish color. Moreover, because the surface of tartar is rough and porous, tartar tends to absorb colors from other sources (e.g., coffee, tea, tobacco, smoke, red wine and the like), and thus the presence of tartar exacerbates cosmetic tooth coloration typically associated with such other sources.
- Typical self-administered techniques for promoting oral health include brushing, flossing, and rinsing with a mouth rinse that typically includes an antimicrobial agent. Although such techniques may work relatively well at mitigating plaque buildup, such techniques are not thought to be effective at removing existing tartar from a surface. Furthermore, although flossing is thought to reduce plaque buildup, relatively few people in the general population floss as often as they should (at least once a day). In a recent study, only 27% of consumers said they flossed once a day.
- The usual methods of preventing tartar buildup include brushing with a tartar control toothpaste. Although such toothpastes, if used regularly, may prevent additional buildup of tartar, the toothpastes are not thought to be effective at removing existing tartar from tooth and device surfaces.
- Typical methods of removing existing tartar typically include scaling or root planing, both of which are performed by dentists or hygienists with the aid of specialized tools. Although these techniques work well, they are relatively expensive and time consuming.
- Accordingly, improved techniques for measurably reducing an amount of tartar, plaque, gingivitis, gum bleeding, periodontitis, and the like are desired.
- The present invention provides a method for measurably improving oral health. More particularly, the invention provides techniques for using a composition, system, and kit. The composition includes one or more active ingredients to measurably reduce an amount of plaque, tartar, gingivitis, including gum bleeding, and/or other periodontal disease, a system includes the composition and a container, and a kit includes a plurality of systems.
- While the ways in which the invention addresses the various drawbacks of known methods will be described in more detail below, in general, the present invention provides a relatively inexpensive, safe technique for the measurable improvement of oral care indices, such as Loe and Silness Gingival Index (1963) (GI), the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI), Volpe-Manhold Index for Calculus (1965) (V-MI). The method is relatively easy to use, does not require a visit to a dentist office, and does not damage the surface of tooth enamel.
- In accordance with various embodiments of the invention, a method for measurably improving oral health includes use of a system that includes a composition, having one or more active ingredients to measurably improve oral health, and a container for enclosing and applying the composition.
- In accordance with one embodiment of the invention, a system includes a viscous composition including at least one active ingredient and a container configured to dispense the viscous composition. In accordance with various aspects of this embodiment, the viscous composition is designed to maintain the active ingredient(s) in contact with a surface for an extended period of time. Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. The viscosity of the compositions may range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp. Suitable active ingredients include cetylpyridinium chloride (CPC), zinc salts, other antimicrobial agents, and other ingredients known to improve (typically reduce) measurable oral health care indices. In accordance with additional aspects of this embodiment, the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses. In accordance with yet further aspects, the container is configured to facilitate application of the composition to specific areas within an oral cavity. In accordance with yet additional aspects of this embodiment, the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- In accordance with another embodiment of the invention, a system includes a composition, having a plurality of active ingredients to measurably improve oral health, and a container to hold the composition. In accordance with various aspects of this embodiment of the invention, the composition includes a carrier having a thickening agent, wherein the composition is configured to maintain the plurality of active ingredients in contact with a surface for an extended period of time. Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to reduce tartar or plaque or gingivitis. In accordance with additional aspects of this embodiment, the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses. In accordance with yet further aspects, the container is configured to facilitate application of the composition to specific areas within an oral cavity. In accordance with yet additional aspects of this embodiment, the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- In accordance with a further embodiment of the invention, a system includes a composition, having one or more active ingredients to measurably improve oral health and a carrier including a thickening agent, and a container to hold the composition. Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, glycerin, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to improve oral health.
- In accordance with additional embodiments, a system includes a container that encapsulates a single dose of the composition. In accordance with alternative embodiments, the container encloses multiple doses.
- In accordance with various additional embodiments, the composition, system, and kit are designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
- In accordance with various additional embodiments, a method includes dispensing a composition from a sealed container by rupturing the sealed container and applying a single dose of the composition directly to the surface. In accordance with another example, the composition is applied after brushing, flossing, and/or rinsing, and is applied before extended rest or bedtime to allow the active ingredients to stay in contact with a surface for an extended period of time
- The exemplary embodiments of the present invention will be described in connection with the appended drawing figures in which like numerals denote like elements and:
-
FIG. 1 illustrates a perspective view of a dispensing device in accordance with exemplary embodiments of the invention; and -
FIGS. 2A-2D illustrate, respectively, left view, front view, right view and a top view of an exemplary container in accordance with an exemplary embodiment of the invention. - The present invention provides a method to measurably improve oral health. More particularly, the invention provides a method for using a composition, system, and kit to measurably improve one or more oral health care indices such as GI, PI, and V-MI. The method of the invention can be used to improve oral health of various animals, is particularly well suited for the treatment of humans.
- As used throughout this application, the term “surface” includes any surface on which plaque, tartar, or gum disease may form. Exemplary surfaces include teeth (both supragingival and subgingival), gums, and dental appliances such as bridges, crowns, fillings, braces, and the like. Further, the term “measurably improve” means a measurable difference between an amount measured without use of the system of the present invention and with or after use of the system. The measurements may be compared for the same surface (before and after) or between test and control groups.
- Viscous Composition
- In accordance with exemplary embodiments of the invention, a method for measurably improving oral health includes a use of a viscous composition, including an active ingredient. As explained in greater detail below, the composition is designed to maintain the active ingredient in contact with a surface for an extended period of time to allow the active ingredient(s) to stay in contact with possibly affected areas on the surface.
- Exemplary active ingredients suitable for use with systems of the invention include one or more of the following: cetylpyridinium chloride (CPC), dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, sodium fluoride, stannous fluoride, sodium monofluorophosphate (MFP), zinc salts such as zinc chloride, zinc acetate, zinc citrate, zinc oxide and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate. Other now known or hereafter devised actives may also be used. For example, any agent, which alone or in combination is able to prevent or alleviate the severity of problems associated with dentition may be utilized. Such may include anti-caries agents and the like; agents useful in reducing tooth hypersensitivity, such as potassium nitrate, strontium chloride and/or the like; and/or plaque and calculus reducing agents, such as, for example, chlorhexidine, quaternary ammonium compounds (e.g. benzethonium chloride, domphen bromide, etc.), triclosan, herbal compounds (e.g. sanguinarine), stannous salts, complex phosphates (e.g., pyrophosphates), SLS (e.g. sodium lauryl sulfate), hydrogen peroxide, and/or the like.
- An amount of the active ingredient for use within compositions suitable for uses with the invention varies in accordance with the dosage size and particular ingredient(s). In general, each active or actives selected will be used in a suitably effective amount, generally on the order of less than about 10 wt %, and more preferably 5 wt % or less. An amount of active may also be desirably selected to be within government guidelines, such as guidelines by the Food and Drug Administration in the USA. In particularly preferred compositions, the active ingredient is present in an amount of about 0.001 wt % to about 1.5 wt %, within an amount of about 0.025 wt % to about 1.0 wt %, or even within an amount about 0.05 wt % to about 0.7 wt %. All percentages set forth herein are in weight percent of the total composition, unless otherwise indicated.
- In accordance with particular examples of this exemplary embodiment of the invention, the active ingredient includes CPC. In one case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%.
- In accordance with other examples, the active ingredient includes zinc gluconate. In one case, the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
- In accordance with further aspects, the composition includes a thickener to obtain the desired viscosity. Suitable thickening agents include substances which increase the viscosity of the composition, cause the composition to gel or coagulate, or the like, such as food-grade or pharmaceutical grade thickeners, including, for example, hydroxyethylcellulose. For example, hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, methyethylecellulose, acceptable non-ionic thickeners, and/or the like. The thickener may be present in an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- The composition may also include a humectant such a glycerin, which may be present in an amount of about 0.01% to about 15%, preferably about 0.1% to about 10%, and more preferably about 1 to about 7%. When used, the humectant may facilitate maintaining the composition in a liquid form and may help maintain a desired viscosity of the composition. In addition, glycerin may facilitate maintaining one or more of the active ingredients in an ionic form and may facilitate the transport of the active ingredients through the composition.
- The composition may also include a suitable diluent. Exemplary diluents for use with the present composition include water, alcohols, and oils. In accordance with particular examples of the invention, the composition includes purified water in an amount of about 80% to about 99%, preferably about 85% to about 95%, and more preferably about 88% to about 92%.
- The composition may also include sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier. When used, sorbitol or other sugar alcohol is present in an amount of about 0.001% to about 0.5%, preferably about 0.01% to about 0.1%, and more preferably about 0.025% to about 0.075%.
- The composition may also include a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
- Colorants may also be added to the composition as desired. In accordance with various aspects, the composition includes colorants, such that when the composition is applied to or proximate the gingiva, the composition has a color indicative of healthy gingiva—i.e., the composition is pink in color. Providing a composition having a color indicative of healthy gingiva provides added incentive to users to continue using the composition, which in turn promotes measurable improvement in oral health indices.
- Colorants may be present in any desired amount. By way of particular example, the colorants may include Red #33 and Red #40, available from Pylam in an amount of about 0.000001% to about 0.00018%, and more preferably about 0.00050% to about 0.00099.
- The composition also optionally includes flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like. By way of one particular example, a composition includes cinnamon oil present in an about of about 0.001% to about 2%, preferably about 0.01% to about 1%, and more preferably about 0.1% to about 0.5%; and clove oil in an amount of about 0.001% to about 2%, preferably about 0.002% to about 1%, and more preferably about 0.003% to about 0.0075%.
- Preferably, the composition is configured to maintain the composition in contact with a surface for an extended period of time, which has several advantages over traditional compositions used to promote oral health. In this regard, preferably the composition is both viscous and exhibits high micro adhesiveness. In accordance with one preferred embodiment, advantageously the composition is both viscous and “sticks” to a surface to which it is applied. In accordance with one aspect of a particularly preferred embodiment of the present invention, the configuration of the composition permits relatively small amounts of the composition and consequently the active agent(s) to be used to effectively prevent or remove plaque and/or tartar buildup on a surface. This is advantageous, not only from an economic viewpoint, but it also reduces an amount of the composition that may be ingested.
- In general, the viscosity of the composition is suitably selected to facilitate easy delivery of the composition from its container, while also maintaining the composition in contact at particular areas within an oral cavity, such as the crevices within teeth and at the tooth gingival margin. In accordance with further embodiments of the invention, the viscosity is low enough to allow application of the composition to desired locations within the oral cavity.
- Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. By way of more particular examples, the viscosity of compositions range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp. The viscosity values as set forth herein are measured using a Brookfield, Model DV-II+ Pro viscometer, spindle # 6, 10 RPM for 90 seconds at 25 C.
- Active Plus Thickener
- In accordance with another embodiment of the invention, a composition includes one or more active ingredients in a carrier, which includes a thickening agent. The active ingredient and thickening agent may include any one or more of the active ingredients and thickening agents noted above in the respective weight percents noted above. The composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
- By way of example, a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients and hydroxyethylcellulose as the thickener. In this case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%; the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%; and the hydroxyethylcellulose is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- Multiple Active Ingredients
- In accordance with another embodiment of the invention, a composition includes multiple active ingredients. The plurality of active ingredients may include any combination of the active ingredients noted above in the weight percents noted above. The composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
- In accordance with one aspect of this embodiment, the composition has a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. By way of more particular examples, the viscosity of compositions ranges from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp. In accordance with another embodiment, the composition includes a thickening agent, which is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
- By way of one particular example, a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients. In one case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25%; and the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
- Active Ingredient and Colorant
- In accordance with this embodiment of the invention, a composition includes one or more active ingredients and a colorant indicative of healthy gingiva. In this case, the color of the composition is more than merely decorative. It serves the function of encouraging those that use the product to continue to use the product because there is an immediate appearance, upon application of the composition, that the composition is promoting healthy gingiva.
- System
-
FIG. 1 andFIGS. 2A-2D illustrate an enclosed, single-dose dispensing system 100 suitable for applying a composition 102 (e.g. a composition described herein) to a surface.System 100 includes aresilient containment portion 104 and anapplicator portion 106.Applicator portion 106 further includes a severed or scarredarea 108 and asealed end 110. -
Composition 102 is dispensed fromsystem 100 by severing or rupturing a portion of device 100 (e.g., at or near scarred area 108) to exposecomposition 102 contained withinsystem 100.Composition 102 is then expelled throughapplicator 106 to a desired area—e.g., a tooth gum margin of a user—by squeezingresilient portion 104 to cause the composition to flow fromresilient portion 104 throughapplicator 106. - As noted above,
system 100 may be configured to apply a composition to a specific area within an oral cavity. In this case,applicator 106 may have a desirably small cross-section acrossapplicator 106. In accordance with specific examples of the present invention, a cross-sectional dimension, taken along line A-A, is about 0.001″ to about 0.2″, preferably about 0.05″ to about 0.01″, and more preferably about 0.06″ to about 0.09″. -
Resilient portion 104 is designed to fit comfortably between two fingers (e.g., a thumb and an index finger) of a user, such that the composition is expelled by pressing the two fingers, on opposite sides ofportion 104, together. In accordance with various examples of the invention,portion 104 has a cross-sectional dimension, taken along line B-B, of about 0.1″ to about 2″, preferably about 0.25″ to about 1″, and more preferably about 0.4″ to about 0.6″. - A single-dose size may vary in accordance with several factors, such as the particular active ingredient, the dilution of the composition, and the like. Exemplary dose sizes for purpose of illustration range from about 0.5 mg to about 8 mg, preferably about 1 mg to about 7 mg, and more preferably about 2 mg to about 5 mg.
- Method of Measurably Improving Oral Health
- A method of measurably improving oral health includes applying a composition including one or more of the active ingredients described herein to a surface and maintaining the composition in contact with the surface for an extended period of time.
- The composition may be applied using a variety of methods such as with a swab, with a syringe, or using any other means capable of dispensing the composition and applying a thin film of gel on the teeth and gums. In accordance with various aspects of this embodiment, the composition is selectively applied using
system 100. More particularly,composition 102 is applied thoughchute 106 to, e.g., a tooth/gingiva interface, such that the composition contacts both supragingival and subgingival areas where plaque and tartar is likely to form. Unlike most methods of promoting oral health, the method of this embodiment allows for direct, selective application of the composition to desired areas of a surface. Thus, less composition may be required to perform the task of measurably improving oral health, because the composition is not ubiquitously applied to an oral cavity. - In accordance with one aspect of this embodiment, a measurable difference of a gingivitis index (e.g., the Loe and Silness Gingival Index (1963)) is obtained by using the system of the present invention. More particularly, a measurable difference in the GI is obtained by applying a composition, e.g., from within the container, to an area (e.g., proximate an inflamed gum tissue, such as at the gum/tooth margin near the inflamed area). In accordance with various aspects of this embodiment, a single dose of the composition is applied after brushing teeth, flossing between teeth, and/or rinsing an oral cavity, and is applied such that the composition remains in contact with the affected area for an extended period of time. By way of particular example, the composition can be applied at before an extended period of rest or bedtime to mitigate disruption of the composition/surface interface and to facilitate maintaining the composition in contact with the surface for an extended period.
- In accordance with another aspect, a measurable difference of a plaque index, e.g., the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI) is obtained by using the method of the present invention.
- In accordance with another aspect, the method is used as described above in connection with obtaining a measurable difference in the GI.
- In accordance with yet a further aspect of this exemplary embodiment, a measurable difference in a tartar index—e.g., the Volpe-Manhold Index (V-MI)—is obtained by using the method of the present invention as described herein. As used herein, a “measurable difference” means a reduction in one or more of the selected indices of on the order of about 20% or more. In accordance with yet another embodiment a measurable improvement in a stain index—e.g., the Lobene Stain Index (SI)—is obtained using the system of the present invention.
- The following non-limiting examples illustrate measurable improvements in various indices using the method in accordance with various embodiments of the invention. These example are merely illustrative, and it is not intended that the invention be limited to the examples. Compositions for use in accordance with the present invention may include the ingredients listed below as well as additional and/or alternative inert materials, preservatives, and other constituents typically found in compositions for promoting oral health. In the case where exemplary inert materials and/or preservatives are listed, these ingredients are merely exemplary, and it is understood that other similar ingredients may be substituted for the materials listed in the examples below.
- A pale light pink viscous gel, having a viscosity of about 40,000 cp, with cinnamon-clove characteristic odor and taste is formed by admixing the following ingredients in the amounts shown.
TABLE 1 Exemplary Ingredient Supplier Weight % Wt % Range Purified Water Copacker 91.603 80-99 Glycerin USP Acme-Hardesty 5.000 0.01-15 HEC 250 HX Hercules-Aqualon 2.000 0.01-10 Sorbitol Roquette 0.050 0.001-0.5 Sucralose Tate & Lyle 0.400 0.001-1.5 Cetylpyridinium Dastech 0.100 0.001-1 Chloride Zinc Gluconate American Ingredients/ 0.592 0.001-1.5 USP Pharmachem Inc. Cinnamon (Oil) Berje 0.250 0.001-2 Clove (Oil) Berje 0.005 0.001-2 Red #40 (1% sol.) Pylam 0.00099 0.000001-0.001 - A clinical study comparing the composition of Example 1 to a placebo and a commercial mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of the 6 week test period, there was an observable/measurable difference in the quality and thickness of calculus in the group using the composition of Example 1, compared to the placebo and the mouth rinse. A significant disruption of calculus bridges or masses of calculus was observed in subjects using the composition of Example 1.
- A visibly noticeable amount of tartar was removed from the surface of the teeth after the six-week period.
- A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the GI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse. The difference was statistically significant (p value≦0.05, based on ANCOVA results, adjusting for baseline value and multiple comparisons) in both absolute and percent improvement of GI between the groups.
- A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the PI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse.
- Although exemplary embodiments of the present invention are set forth herein, it should be appreciated that the invention is not so limited. Various modifications, variations, and enhancements in composition and method set forth herein may be made without departing from the spirit and scope of the present invention.
Claims (20)
1. A method to measurably improve an oral health index comprising:
a. providing at least one system, the at least one system including a composition within a container wherein the composition comprises an active ingredient for measurably improving oral health; and
b. applying the composition to a surface within an oral cavity;
wherein the oral health index comprises at least one of a gingival index, a plaque index and a calculus index and wherein the viscosity of the composition is greater than about 20,000 centipoise.
2. The method of claim 1 , wherein the viscosity of the composition is about 20,000 centipoise to about 250,000 centipoise.
3. The method of claim 2 , wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
4. The method of claim 3 , wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
5. The method of claim 1 , wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts such as zinc chloride, zinc acetate, zinc citrate, and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
6. The method of claim 1 , further comprising a kit including a plurality of systems.
7. A method to measurably reduce existing tartar comprising:
a. providing a system including a composition within a container, the composition including an active ingredient and a thickening agent for measurably reducing existing tartar and the container including a resilient vial and a spout for targeted delivery of the composition; and
b. applying the composition to a surface within an oral cavity.
8. The method of claim 7 , wherein the viscosity of the composition is about 20,000 centipoise to about 250,000 centipoise.
9. The method of claim 8 , wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
10. The method of claim 9 , wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
11. The method of claim 7 , wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
12. The method of claim 7 , wherein the thickening agent comprises at least one of hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, and methyethylecellulose.
13. The method of claim 12 wherein the thickening agent is present in an amount of about 0.01 wt % to about 10 wt %.
14. The method of claim 13 , wherein the thickening agent is present in an amount of about 0.1 wt % to about 7 wt %.
15. The method of claim 14 , wherein the thickening agent is present in an amount of about 1 wt % to about 5 wt %.
16. A method to measurably improve an oral health index comprising the steps of:
a. providing at least one system, the at least one system including a composition within a container, wherein the composition comprises a plurality of active ingredients for measurably improving oral health and a thickener;
b. applying the composition to a surface within an oral cavity; and
c. maintaining the composition in contact with the surface for an extended period of time;
wherein the oral health index comprises at least one of a gingival index, a plaque index and a calculus index.
17. The method of claim 11 , wherein the viscosity of the composition is greater than about 20,000 centipoise.
18. The method of claim 13 , wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
19. The method of claim 14 , wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
20. The method of claim 16 , wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts such as zinc chloride, zinc acetate, zinc citrate, and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/749,099 US20070292364A1 (en) | 2006-05-15 | 2007-05-15 | Method for measurably improving oral health |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80063206P | 2006-05-15 | 2006-05-15 | |
US11/749,099 US20070292364A1 (en) | 2006-05-15 | 2007-05-15 | Method for measurably improving oral health |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070292364A1 true US20070292364A1 (en) | 2007-12-20 |
Family
ID=38617294
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/748,657 Abandoned US20070292362A1 (en) | 2006-05-15 | 2007-05-15 | Method for orthodontia care |
US12/300,995 Active 2029-09-07 US9072673B2 (en) | 2006-05-15 | 2007-05-15 | Method for measurably improving oral health |
US11/748,661 Abandoned US20070292363A1 (en) | 2006-05-15 | 2007-05-15 | Method for prevention and treatment of periodontal disease |
US11/749,099 Abandoned US20070292364A1 (en) | 2006-05-15 | 2007-05-15 | Method for measurably improving oral health |
US11/749,138 Abandoned US20070292370A1 (en) | 2006-05-15 | 2007-05-15 | Method for improving oral health |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/748,657 Abandoned US20070292362A1 (en) | 2006-05-15 | 2007-05-15 | Method for orthodontia care |
US12/300,995 Active 2029-09-07 US9072673B2 (en) | 2006-05-15 | 2007-05-15 | Method for measurably improving oral health |
US11/748,661 Abandoned US20070292363A1 (en) | 2006-05-15 | 2007-05-15 | Method for prevention and treatment of periodontal disease |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/749,138 Abandoned US20070292370A1 (en) | 2006-05-15 | 2007-05-15 | Method for improving oral health |
Country Status (2)
Country | Link |
---|---|
US (5) | US20070292362A1 (en) |
WO (1) | WO2007134335A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010009119A2 (en) | 2008-07-15 | 2010-01-21 | Basf Catalysts Llc | Tooth whitening compositions and methods |
US20100196512A1 (en) | 2009-02-04 | 2010-08-05 | Basf Catalyst Llc | Treatment of Non-Oral Biological Tissue with Chlorine Dioxide |
DK2418945T3 (en) | 2009-04-15 | 2019-02-25 | Bmg Pharma S P A | Mineral salt-sulfonic acid compositions and methods of use |
CA2825137A1 (en) * | 2010-01-22 | 2011-07-28 | University Of Louisville Research Foundation, Inc | Methods of treating or preventing periodontitis and diseases associated with periodontitis |
SG185628A1 (en) * | 2010-06-30 | 2012-12-28 | Colgate Palmolive Co | Oral health index |
EP2600833B1 (en) | 2010-08-07 | 2017-03-08 | The Research Foundation for The State University of New York | Oral compositions comprising a zinc compound and an anti-microbial agent |
JP6574150B2 (en) * | 2016-08-10 | 2019-09-11 | 小林製薬株式会社 | Oral composition |
MX2020014311A (en) | 2018-06-25 | 2021-04-28 | Triumph Pharmaceuticals Inc | Methods of inhibiting microbial infections using zinc-containing compositions. |
US10927397B2 (en) | 2018-10-16 | 2021-02-23 | Sterilex, Llc | Compositions, devices and methods for detecting biofilms |
BR112022016384A2 (en) | 2020-02-18 | 2022-10-11 | Sunstar Americas Inc | ORAL CARE COMPOSITION |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4134511A (en) * | 1976-11-27 | 1979-01-16 | Stella Kg Werner Deussen | Container with frangible seal |
US4941520A (en) * | 1986-05-16 | 1990-07-17 | Dowzall Martin E | Formulating pasty materials |
US5755572A (en) * | 1992-08-10 | 1998-05-26 | Novadent Ltd. | Oral hygiene irrigator syringe bulb |
US5948390A (en) * | 1997-08-25 | 1999-09-07 | Pfizer Inc. | Stable zinc/citrate/CPC oral rinse formulations |
US6095813A (en) * | 1999-06-14 | 2000-08-01 | 3M Innovative Properties Company | Method for applying a dental composition to tooth structure |
US6355229B1 (en) * | 2001-06-27 | 2002-03-12 | Church & Dwight Co., Inc. | Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same |
US20030003059A1 (en) * | 2001-04-03 | 2003-01-02 | Frederic Dana | Dentifrice compositions |
US20040131559A1 (en) * | 2002-11-04 | 2004-07-08 | Hauck Douglas J. | Oral disease prevention and treatment |
US20050026107A1 (en) * | 2003-07-28 | 2005-02-03 | Britesmile Development, Inc. | Therapeutic responsive dental gel composition |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB337383A (en) | 1929-07-26 | 1930-10-27 | Josua Gabriel Paulin | Improvements in mouth and tooth cleansing apparatus |
US2029483A (en) | 1934-08-15 | 1936-02-04 | James J Holland | Water syringe |
US3199510A (en) | 1962-08-27 | 1965-08-10 | William W Sinai | Hygienic dental device |
US4242323A (en) | 1979-08-22 | 1980-12-30 | Vlock D G | Plaque inhibiting oral composition |
US4664906A (en) * | 1984-08-30 | 1987-05-12 | Johnson & Johnson Products Inc. | Oral compositions |
US4814163A (en) * | 1986-03-10 | 1989-03-21 | Colgate-Palmolive Company | Solid antitartar mouth deodorant |
DE8632961U1 (en) | 1986-12-09 | 1987-01-29 | Stella-KG. Werner Deussen, 6228 Eltville | Container with breakable closure |
GB2210264A (en) | 1987-10-02 | 1989-06-07 | Richardson Vicks Ltd | Antigingival/antiplaque compositions |
US4966312A (en) | 1988-12-06 | 1990-10-30 | Waring Donald A | Disposable oral liquid measure dispenser |
WO1990015592A1 (en) | 1989-06-12 | 1990-12-27 | Patrick John Shanahan | Anti-plaque dentifrice |
US5094845A (en) * | 1991-03-04 | 1992-03-10 | David G. Vlock | Oral compositions containing zinc gluconate complexes |
US5246371A (en) * | 1992-08-31 | 1993-09-21 | Ultradent Products, Inc. | Method and apparatus for delivery of highly filled, thixotropic sealant to teeth |
US5578295A (en) | 1995-04-28 | 1996-11-26 | The Procter & Gamble Company | Oral care compositions comprising certain substituted diphenyl ethers |
ATE287673T1 (en) * | 1995-06-07 | 2005-02-15 | Southern Biosystems Inc | CONTROLLED FEED SYSTEM WITH A HIGH VISCOSITY LIQUID |
US6425704B2 (en) | 2000-01-07 | 2002-07-30 | Closure Medical Corporation | Adhesive applicators with improved applicator tips |
US6723305B2 (en) * | 2002-03-04 | 2004-04-20 | Colgate Palmolive Company | Anti-microbial breath freshening mouthrinse |
EP1393710A1 (en) * | 2002-08-21 | 2004-03-03 | The Procter & Gamble Company | A method of applying an oral composition |
US6861049B2 (en) * | 2002-11-12 | 2005-03-01 | Douglas B. Harwood | Aqueous slurries useful for cleaning the tongue and throat |
WO2004071321A2 (en) | 2003-02-05 | 2004-08-26 | Fmc Corporation | Toothpaste compositions with reduced abrasivity |
US6932603B2 (en) | 2003-08-08 | 2005-08-23 | Johnny Steve Han | Interproximal squirt brush |
US7306121B2 (en) | 2005-03-21 | 2007-12-11 | Hygiene-Technik Inc. | Gooseneck squeezable dispenser |
-
2007
- 2007-05-15 US US11/748,657 patent/US20070292362A1/en not_active Abandoned
- 2007-05-15 US US12/300,995 patent/US9072673B2/en active Active
- 2007-05-15 US US11/748,661 patent/US20070292363A1/en not_active Abandoned
- 2007-05-15 US US11/749,099 patent/US20070292364A1/en not_active Abandoned
- 2007-05-15 WO PCT/US2007/068999 patent/WO2007134335A2/en active Application Filing
- 2007-05-15 US US11/749,138 patent/US20070292370A1/en not_active Abandoned
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4134511A (en) * | 1976-11-27 | 1979-01-16 | Stella Kg Werner Deussen | Container with frangible seal |
US4941520A (en) * | 1986-05-16 | 1990-07-17 | Dowzall Martin E | Formulating pasty materials |
US5755572A (en) * | 1992-08-10 | 1998-05-26 | Novadent Ltd. | Oral hygiene irrigator syringe bulb |
US5948390A (en) * | 1997-08-25 | 1999-09-07 | Pfizer Inc. | Stable zinc/citrate/CPC oral rinse formulations |
US6095813A (en) * | 1999-06-14 | 2000-08-01 | 3M Innovative Properties Company | Method for applying a dental composition to tooth structure |
US20030003059A1 (en) * | 2001-04-03 | 2003-01-02 | Frederic Dana | Dentifrice compositions |
US6355229B1 (en) * | 2001-06-27 | 2002-03-12 | Church & Dwight Co., Inc. | Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same |
US20040131559A1 (en) * | 2002-11-04 | 2004-07-08 | Hauck Douglas J. | Oral disease prevention and treatment |
US20050026107A1 (en) * | 2003-07-28 | 2005-02-03 | Britesmile Development, Inc. | Therapeutic responsive dental gel composition |
Also Published As
Publication number | Publication date |
---|---|
WO2007134335A3 (en) | 2008-01-24 |
US9072673B2 (en) | 2015-07-07 |
WO2007134335A2 (en) | 2007-11-22 |
US20070292363A1 (en) | 2007-12-20 |
US20090257963A1 (en) | 2009-10-15 |
US20070292370A1 (en) | 2007-12-20 |
US20070292362A1 (en) | 2007-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070292364A1 (en) | Method for measurably improving oral health | |
Malhotra et al. | Comparison of the effectiveness of a commercially available herbal mouthrinse with chlorhexidine gluconate at the clinical and patient level | |
Keijser et al. | Comparison of 2 commercially available chlorhexidine mouthrinses | |
CN110996891B (en) | Gel comprising chlorhexidine | |
Farah et al. | Mouthwashes | |
US8303938B2 (en) | Anti-calculus dental composition | |
US20070292369A1 (en) | Method for preventing and reducing tartar buildup | |
US20070292366A1 (en) | System, kit and method for promoting and maintaining oral health | |
Maden et al. | The Efficacy of Xylitol, Xylitol-Probiotic and Fluoride Dentifrices in Plaque Reduction and Gingival Inflammation in Children: A Randomised Controlled Clinical Trial. | |
US20070098650A1 (en) | Dental formulation | |
US20070292365A1 (en) | Method of mitigating and disrupting tartar buildup | |
US8871183B2 (en) | Composition for promoting and maintaining oral health | |
US20070292367A1 (en) | Method and system for facilitating and maintaining oral health through prescribed applications of oral compositions | |
US20230000738A1 (en) | Oral Care Compositions and Methods | |
BR112021008102A2 (en) | oral mucosa carrier and protector | |
JP2548265B2 (en) | Oral hygiene medicine | |
US20070292372A1 (en) | Gel composition for improving oral health, system including the composition, and methods of using and forming same | |
US20070292531A1 (en) | Composition for oral use and methods for application of same | |
Pader | Dental products | |
US20210015734A1 (en) | Oral Care Products and Methods | |
US20070292368A1 (en) | Oral care composition | |
US20240342074A1 (en) | Teeth whitening products | |
ITMI20000710A1 (en) | NEW FORMULATIONS FOR THE REMOVAL OF DENTAL PLATE AND TARTAR | |
Llena et al. | Anticalculus efficacy of a new dentifrice. | |
Janeshin et al. | Effect of an Iranian Toothpaste Compared with a Commonly Used Foreign-Made Toothpasteon Plaque Index of 9-to 12-Year-Old children: a clinical trial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MATRIXX ORAL CARE, LLC, ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CLAROT, TIM;MISKEWITZ, REGINA;REEL/FRAME:019821/0063;SIGNING DATES FROM 20070801 TO 20070806 Owner name: ZICARE, LLC, ARIZONA Free format text: CHANGE OF NAME;ASSIGNOR:MATRIXX ORAL CARE, LLC;REEL/FRAME:019821/0720 Effective date: 20070815 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |